Roche Holding AG Basel American Depositary Shares (OP:RHHBY)

52.66 +0.07 (+0.13%)

Streaming Delayed Price Updated: 10:46 AM EST, Dec 24, 2025 Add to My Watchlist

Price and Volume

Volume	177,315
Open	53.00
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	52.59
Today's Range	52.50 - 53.00
52wk Range	34.17 - 52.59
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Novo Nordisk Stock Soars as "Wegovy Pill" Gains FDA Approval, Reshaping Obesity Market

December 23, 2025

Shares of Novo Nordisk (NYSE: NVO) surged more than 8% in early trading on December 23, 2025, after the pharmaceutical giant secured a landmark FDA approval for its high-dose oral semaglutide, branded...

Via MarketMinute

FDA Approves Genentech’s Lunsumio VELO™ for Subcutaneous Use in Relapsed or Refractory Follicular Lymphoma

December 22, 2025

From Genentech

Via Business Wire

Performance

YTD	+50.7%	+50.7%
1 Month	+10.6%	+10.6%
3 Month	+26.1%	+26.1%
6 Month	+29.1%	+29.1%
1 Year	+50.9%	+50.9%

More News

Trump Strikes New Drug-Price Deals With Roche, Novartis, Merck And Other Pharma Giants ↗

December 19, 2025

Via Stocktwits

Genentech Announces Agreement With U.S. Government

December 19, 2025

From Genentech

Via Business Wire

Novartis US Stock Rises On Reports Of White House Pricing Deal Due Friday — Roche Also In Talks ↗

December 17, 2025

Via Stocktwits

Genentech’s Giredestrant Reduced Risk of Invasive Disease Recurrence or Death by 30% in ER-positive Early-Stage Breast Cancer

December 10, 2025

From Genentech

Via Business Wire

Genentech Presents Lunsumio Data Showing Potential Across Earlier Treatment Lines in Indolent and Aggressive Lymphomas

December 08, 2025

From Genentech

Via Business Wire

Is Alnylam Pharmaceuticals a Millionaire Maker? ↗

December 07, 2025

Via The Motley Fool

Should You Buy This Biotech Stock That Just Gained 5% in 1 Day? ↗

November 30, 2025

Via The Motley Fool

Pharma Bro Martin Shkreli Shorts Olema Pharmaceuticals Stock ↗

November 18, 2025

Via Benzinga

OLMA Stock Doubles After Roche Cancer Drug Trial Yields Positive Results ↗

November 18, 2025

Via Stocktwits

Cancer Focused Olema Pharmaceuticals Stock Soars 150% - Here's Why ↗

November 18, 2025

Via Benzinga

Why Roche's Positive Test Results Sent Olema Pharma Skyrocketing 200% ↗

November 18, 2025

Via Investor's Business Daily

2 No-Brainer Healthcare Stocks to Buy Now ↗

November 18, 2025

Via The Motley Fool

Genentech’s Giredestrant Becomes the First Oral SERD to Show Superior Invasive Disease-Free Survival in Early Breast Cancer

November 18, 2025

From Genentech

Via Business Wire

Magnificent Seven Will Become Low-Profit Tech Utilities, Analyst Warns ↗

November 17, 2025

Via Benzinga

Jazz, Zymeworks Catapult On Their 'Sweeping Success' In Gastric Cancer ↗

November 17, 2025

Via Investor's Business Daily

Why Roche Holding Stock Popped Today ↗

November 10, 2025

Via The Motley Fool

TG Therapeutics Crumbles After Roche Unveils Its 'Unprecedented' Test Results ↗

November 10, 2025

Via Investor's Business Daily

Multimodal AI Unleashes New Era in Cancer Research: A Revolution in Diagnosis and Treatment

November 10, 2025

Via TokenRing AI

Genentech’s Fenebrutinib Shows Unprecedented Positive Phase III Results as the Potential First and Only BTK Inhibitor in Both Relapsing and Primary Progressive Multiple Sclerosis

November 10, 2025

From Genentech

Via Business Wire

Celcuity Eyeing Cancer Treatment Riddle. Stock Flys 534% This Year. ↗

November 05, 2025

Via Investor's Business Daily

AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential

November 04, 2025

Via TokenRing AI

Genentech to Present New Data From Its Broad and Innovative Hematology Portfolio at ASH 2025

November 03, 2025

From Genentech

Via Business Wire

Positive Phase III Data for Genentech’s Gazyva Show Significant Reduction in Disease Activity for Systemic Lupus Erythematosus

November 03, 2025

From Genentech

Via Business Wire

Frequently Asked Questions

Is Roche Holding AG Basel American Depositary Shares publicly traded?

Yes, Roche Holding AG Basel American Depositary Shares is publicly traded.

What exchange does Roche Holding AG Basel American Depositary Shares trade on?

Roche Holding AG Basel American Depositary Shares trades on the OTC Traded

What is the ticker symbol for Roche Holding AG Basel American Depositary Shares?

The ticker symbol for Roche Holding AG Basel American Depositary Shares is RHHBY on the OTC Traded

What is the current price of Roche Holding AG Basel American Depositary Shares?

The current price of Roche Holding AG Basel American Depositary Shares is 52.66

When was Roche Holding AG Basel American Depositary Shares last traded?

The last trade of Roche Holding AG Basel American Depositary Shares was at 12/24/25 10:46 AM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.